National Institute of Mental Health; Amended Notice of Meeting, 34545 [2017-15512]
Download as PDF
Federal Register / Vol. 82, No. 141 / Tuesday, July 25, 2017 / Notices
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting)
Contact Person: Luis Dettin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2208,
Bethesda, MD 20892, 301–451–1327,
dettinle@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: July 19, 2017.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15514 Filed 7–24–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Clinical Trials, National Institutes of Health,
National Cancer Institute, Coordinating
Center for Clinical Trials, 9609 Medical
Center Drive, Room 6W136, Rockville, MD
20850, 240–276–6173, prindivs@
mail.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for entrance
onto the NIH campus. All visitor vehicles,
including taxicabs, hotel, and airport shuttles
will be inspected before being allowed on
campus. Visitors will be asked to show one
form of identification (for example, a
government-issued photo ID, driver’s license,
or passport) and to state the purpose of their
visit.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/ctac/ctac.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
mstockstill on DSK30JT082PROD with NOTICES
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Cancer Institute Clinical Trials
and Translational Research Advisory
Committee.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will also be videocast and can be
accessed from the NIH Videocasting and
Podcasting Web site (https://
videocast.nih.gov/).
[FR Doc. 2017–15515 Filed 7–24–17; 8:45 am]
Name of Committee: National Cancer
Institute Clinical Trials and Translational
Research Advisory Committee.
Date: November 1, 2017.
Time: 8:00 a.m. to 3:00 p.m.
Agenda: Strategic Discussion of NCI’s
Clinical and Translational Research
Programs.
Place: National Institutes of Health,
Building 31, C-Wing, 6th Floor, Room 9 and
10, 31 Center Drive, Bethesda, MD 20892.
Contact Person: Sheila A. Prindiville, MD,
MPH, Director, Coordinating Center for
Notice is hereby given of a change in
the meeting of the Interagency Autism
Coordinating Committee, July 26, 2017,
09:00 a.m. to July 26, 2017, 05:00 p.m.,
National Institutes of Health, Building
31, 31 Center Drive, Conference Room 6,
Bethesda, MD 20892 which was
published in the Federal Register on
April 03, 2017, 82 FR 16217.
The meeting is being amended to
change the conference call access
CBPL No.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health;
Amended Notice of Meeting
ASTM
27–01 ..............
27–02 ..............
D 287
D 1298
27–03 ..............
27–04 ..............
D 4006
D 95
VerDate Sep<11>2014
Dated: July 19, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
19:30 Jul 24, 2017
34545
number from 1–800–323- 2720 to 1–
888–323–2720. The meeting is open to
the public.
Dated: July 18, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2017–15512 Filed 7–24–17; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Accreditation of Intertek USA, Inc., as
a Commercial Laboratory
U.S. Customs and Border
Protection, Department of Homeland
Security.
ACTION: Notice of accreditation of
Intertek USA, Inc., as a commercial
laboratory.
AGENCY:
Notice is hereby given,
pursuant to CBP regulations, that
Intertek USA, Inc., has been accredited
to test petroleum and certain petroleum
products for customs purposes for the
next three years as of August 24, 2016.
DATES: Intertek USA, Inc., was
accredited as commercial laboratory as
of August 24, 2016. The next triennial
inspection date will be scheduled for
August 2019.
FOR FURTHER INFORMATION CONTACT: Dr.
Justin Shey, Laboratories and Scientific
Services Directorate, U.S. Customs and
Border Protection, 1300 Pennsylvania
Avenue NW., Suite 1500N, Washington,
DC 20229, tel. 202–344–1060.
SUPPLEMENTARY INFORMATION: Notice is
hereby given pursuant to 19 CFR 151.12,
that Intertek USA, Inc., 1114 Seaco
Avenue, Deer Park, TX 77536, has been
accredited to test petroleum and certain
petroleum products for customs
purposes, in accordance with the
provisions of 19 CFR 151.12. Intertek
USA, Inc., is accredited for the
following laboratory analysis
procedures and methods for petroleum
and certain petroleum products set forth
by the U.S. Customs and Border
Protection Laboratory Methods (CBPL)
and American Society for Testing and
Materials (ASTM):
SUMMARY:
Title
Standard Test Method for API Gravity of Crude Petroleum and Petroleum Products (Hydrometer Method).
Standard Test Method for Density, Relative Density (Specific Gravity), or API Gravity of Crude Petroleum and Liquid Petroleum Products by Hydrometer Method.
Standard Test Method for Water in Crude Oil by Distillation.
Standard Test Method for Water in Petroleum Products and Bituminous Materials by Distillation.
Jkt 241001
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
E:\FR\FM\25JYN1.SGM
25JYN1
Agencies
[Federal Register Volume 82, Number 141 (Tuesday, July 25, 2017)]
[Notices]
[Page 34545]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-15512]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Mental Health; Amended Notice of Meeting
Notice is hereby given of a change in the meeting of the
Interagency Autism Coordinating Committee, July 26, 2017, 09:00 a.m. to
July 26, 2017, 05:00 p.m., National Institutes of Health, Building 31,
31 Center Drive, Conference Room 6, Bethesda, MD 20892 which was
published in the Federal Register on April 03, 2017, 82 FR 16217.
The meeting is being amended to change the conference call access
number from 1-800-323- 2720 to 1-888-323-2720. The meeting is open to
the public.
Dated: July 18, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-15512 Filed 7-24-17; 8:45 am]
BILLING CODE 4140-01-P